Form 8-K - Current report:
SEC Accession No. 0000950123-05-005808
Filing Date
2005-05-06
Accepted
2005-05-06 17:13:48
Documents
4
Period of Report
2005-05-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y08784e8vk.txt 8-K 5858
2 EX-99.1: PRESS RELEASE y08784exv99w1.txt EX-99.1 18742
3 EX-99.2: PRESS RELEASE y08784exv99w2.txt EX-99.2 11242
4 EX-99.3: PRESS RELEASE y08784exv99w3.txt EX-99.3 19598
  Complete submission text file 0000950123-05-005808.txt   57136
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1204
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 05808981
SIC: 2835 In Vitro & In Vivo Diagnostic Substances